Melissa Lipari Pharm.D., BCACP

Melissa Lipari Pharm.D., BCACP

Title

Assistant Professor (Clinical)

Office Location

Room 4137

Phone

313-993-7685

Email

mlipari@wayne.edu

Department

Pharmacy Practice

Melissa Lipari Pharm.D., BCACP

Degrees and Certifications

  • Board Certified Ambulatory Care Pharmacist®, Board of Pharmacy Specialties, 2012-present
  • Doctor of Pharmacy, Wayne State University, 2010
  • Pre-pharmacy studies, Wayne State University, 2006
  • PGY2 Ambulatory Care Residency, DMC Harper University Hospital, 2012
  • PGY1 Pharmacy Practice Residency, DMC Harper University Hospital, 2011

Positions and Employment

  • Assistant Professor, Pharmacy Practice, Wayne State University, 2012-present
  • Ambulatory Care Clinical Pharmacy Specialist, St. John Hospital and Medical Center, 2012-present

Awards and Honors

  • ASHP Foundation Research Bootcamp Grant, 2014
  • Resident of the Year, Southeastern Michigan Society of Health-System Pharmacists, 2012
  • Second Runner Up, ACCP Ambulatory Care/Endocrine Metabolism PRN Walk Rounds, American College of Clinical Pharmacy Annual Meeting 2012. Johnson J, Garwood C, Moser LR, Lipari M. "Pharmacist Interventions and Healthcare Outcomes in a Novel Heart Failure Clinic."
  • First Place Winner, Cardiac Care Team Poster Competition, Michigan Chapter ACC, Cardiovascular Summit 2012. Lipari M, Jones JL, Moser L. "Pharmacist Roles during the Transitions of Care for Heart Failure Patients."

Professional Memberships

  • American Society of Health-System Pharmacists
  • Michigan Society of Health-System Pharmacists
  • Michigan Pharmacists Association
  • American College of Clinical Pharmacy

Areas of Expertise

  • Chronic obstructive pulmonary disease (COPD)

Recent Publications

  1. Lipari M, Smith AL, Kale-Pradhan PB*, Wilhelm SM. Adherence to GOLD Guidelines in the Inpatient COPD Population. Journal of Pharmacy Practice. 2018, 31 (1): 29-33. DOI: 10.1177/0897190017696949
  2. Lipari M, Moser LR*, Petrovitch EA, Farber M, Flack JM. As Needed IV Antihypertensive Therapy and Blood Pressure Control. J Hosp Med. 2016;11(3):193-8. DOI: 10.1002/jhm.2510. Published online first – Nov. 12, 2015.
  3. Wilhelm SM, Lipari M, Kulik JK, Kale-Pradhan PB*. Teduglutide. Ann Pharmacother. 2014:48(9) 1209–13. DOI: 10.1177/1060028014537468
  4. Lipari M, Kale-Pradhan PB*. Vulnerable COPD patients with comorbidities: the role of roflumilast. Ther Clin Risk Manag. 2014;10:969-976. DOI: 10.2147/TCRM.S55105
  5. Lipari M, Benipal H, Kale-Pradhan P*. Roflumilast in the management of Chronic Obstructive Pulmonary Disease. Am J Health-Syst Pharm. 2013;70: 2087-95. DOI: 10.2146/ajhp130114